Recordati Industria Chimica e Farmaceutica S.p.A.

Milan Stock Exchange REC.MI

Recordati Industria Chimica e Farmaceutica S.p.A. Price to Sales Ratio (P/S) on January 14, 2025: 4.94

Recordati Industria Chimica e Farmaceutica S.p.A. Price to Sales Ratio (P/S) is 4.94 on January 14, 2025, a -0.11% change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.
  • Recordati Industria Chimica e Farmaceutica S.p.A. 52-week high Price to Sales Ratio (P/S) is 5.34 on October 17, 2024, which is 8.09% above the current Price to Sales Ratio (P/S).
  • Recordati Industria Chimica e Farmaceutica S.p.A. 52-week low Price to Sales Ratio (P/S) is 4.60 on June 17, 2024, which is -6.80% below the current Price to Sales Ratio (P/S).
  • Recordati Industria Chimica e Farmaceutica S.p.A. average Price to Sales Ratio (P/S) for the last 52 weeks is 4.97.
Key data
Date Price to Sales Ratio (P/S) Price to Book Ratio (P/B) Dividend Yield Free Cash Flow Yield
Market news
Loading...
Milan Stock Exchange: REC.MI

Recordati Industria Chimica e Farmaceutica S.p.A.

CEO Dr. Robert Koremans M.D.
IPO Date March 28, 1995
Location Italy
Headquarters 1, Via Matteo Civitali
Employees 4,450
Sector Health Care
Industries
Description

Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, marketing, and sale of pharmaceuticals worldwide. The company offers pharmaceuticals in various therapeutic areas, including cardiovascular, dermatology, over the counter/non-prescription pharmaceuticals, urology, anti-infectives, central nervous system, gastrointestinal, gynecology and obstetrics, musculo-skeletal disorders and analgesia, nutrition and related products, cosmetics, dietary supplements, medical devices, allergy, endocrinology, respiratory, pain management/inflammation, generics, antipyretics and cold preparations, and oncology, as well as ear, nose, and throat. It also provides products for rare diseases; and pharmaceutical chemicals, such as chemical syntheses, active pharmaceutical ingredients, and intermediates. The company was founded in 1926 and is headquartered in Milan, Italy. Recordati Industria Chimica e Farmaceutica S.p.A. operates as a subsidiary of Rossini S.à R.L.

Similar companies

CPR.MI

Davide Campari-Milano N.V.

USD 5.59

-2.10%

AMP.MI

Amplifon S.p.A.

USD 26.82

1.34%

BRE.MI

Brembo S.p.A.

USD 8.91

-0.66%

DIA.MI

DiaSorin S.p.A.

USD 103.47

-0.44%

PRY.MI

Prysmian S.p.A.

USD 65.92

0.76%

StockViz Staff

January 15, 2025

Any question? Send us an email